247 related articles for article (PubMed ID: 15339761)
1. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
Cardozo L; Drutz HP; Baygani SK; Bump RC
Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine versus placebo in the treatment of stress urinary incontinence.
Norton PA; Zinner NR; Yalcin I; Bump RC;
Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
Lin AT; Sun MJ; Tai HL; Chuang YC; Huang ST; Wang N; Zhao YD; Beyrer J; Wulster-Radcliffe M; Levine L; Chang C; Viktrup L
BMC Urol; 2008 Jan; 8():2. PubMed ID: 18221532
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
10. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response.
Bump RC; Norton PA; Zinner NR; Yalcin I;
Obstet Gynecol; 2003 Jul; 102(1):76-83. PubMed ID: 12850610
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
[TBL] [Abstract][Full Text] [Related]
14. [Place of duloxetine in the treatment of stress urinary incontinence].
Rouprêt M; Richard F; Chartier-Kastler E
Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine: in stress urinary incontinence.
McCormack PL; Keating GM
Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in women awaiting surgery.
Drutz H
BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations).
Weinstein DL; Cohen JS; Liu C; Meadows ES; Plouffe L; Muram D;
Curr Med Res Opin; 2006 Nov; 22(11):2121-9. PubMed ID: 17076972
[TBL] [Abstract][Full Text] [Related]
19. Postprostatectomy established stress urinary incontinence treated with duloxetine.
Collado Serra A; Rubio-Briones J; Puyol Payás M; Iborra Juan I; Ramón-Borja JC; Solsona Narbón E
Urology; 2011 Aug; 78(2):261-6. PubMed ID: 21601255
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine treatment for women awaiting continence surgery.
Duckett JR; Aggarwal I; Patil A
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Nov; 17(6):563-5. PubMed ID: 16416257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]